EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Imatinib detection by memristive biosensors for therapeutic drug monitoring

Junrui Chen, Lavinia Alberi, Yuan Pétermann, Thierry Buclin, Monia Guidi, Sandro Carrara

Biosensors and Bioelectronics: X · 2025-08 · 24 · 100620

DOI: 10.1016/j.biosx.2025.100620 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics: X, 2025-08. Verfasst von Junrui Chen und 5 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: École Polytechnique Fédérale de Lausanne, Innosuisse Swiss Innovation Agency.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic drug monitoring is essential for optimizing the efficacy and safety of targeted anticancer agents like imatinib, a first-line treatment for various leukemias and gastrointestinal stromal tumors. This study introduces a novel memristive biosensor designed for the detection of imatinib. The biosensor employs a silicon nanowire (SiNW)-based memristive architecture integrated with a single-stranded DNA (ssDNA) aptamer as the biorecognition element. Imatinib detection is successfully demonstrated in both buffer and human plasma. While the interfering proteins such as human serum albumin (HSA) and α1-acid glycoprotein (AGP) compete with the binding mechanism, resulting in a decreased measured signal at lower concentrations, their excessive presence paradoxically amplifies the measured signal. This amplification, however, also introduces increased variability in plasma measurements. Despite these challenges, this innovative memristive biosensor represents a significant advancement towards point-of-care therapeutic drug monitoring. It offers a robust and scalable platform, paving the way for the integration of personalized medicine into routine clinical workflows for imatinib-based therapies.

Förderung

  • École Polytechnique Fédérale de Lausanne
  • Innosuisse Swiss Innovation Agency

Zitieren

APA

Chen, J., Alberi, L., Pétermann, Y., Buclin, T., Guidi, M., & Carrara, S. (2025). Imatinib detection by memristive biosensors for therapeutic drug monitoring. Biosensors and Bioelectronics: X, 24, 100620. https://doi.org/10.1016/j.biosx.2025.100620

Vancouver

Chen J, Alberi L, Pétermann Y, Buclin T, Guidi M, Carrara S. Imatinib detection by memristive biosensors for therapeutic drug monitoring. Biosensors and Bioelectronics: X. 2025;24:100620. doi:10.1016/j.biosx.2025.100620

BibTeX
@article{Chen2025,
  author = {Chen, Junrui and Alberi, Lavinia and Pétermann, Yuan and Buclin, Thierry and Guidi, Monia and Carrara, Sandro},
  title = {Imatinib detection by memristive biosensors for therapeutic drug monitoring},
  journal = {Biosensors and Bioelectronics: X},
  year = {2025},
  volume = {24},
  pages = {100620},
  doi = {10.1016/j.biosx.2025.100620}
}
Kostenlos starten →